Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totaling 342,847 shares, an increase of 286.3% from the September 30th total of 88,752 shares. Currently, 14.9% of the company’s shares are sold short. Based on an average daily volume of 5,307,777 shares, the short-interest ratio is presently 0.1 days.
Arcadia Biosciences Price Performance
NASDAQ:RKDA traded down $0.00 during trading hours on Wednesday, hitting $0.16. 69,605 shares of the company were exchanged, compared to its average volume of 1,523,769. The company’s 50 day moving average price is $0.36 and its 200-day moving average price is $1.06. Arcadia Biosciences has a 52-week low of $0.11 and a 52-week high of $4.18. The stock has a market capitalization of $381,021.00, a price-to-earnings ratio of -0.03 and a beta of 0.56.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its earnings results on Thursday, August 13th. The basic materials company reported ($2.09) EPS for the quarter, missing analysts’ consensus estimates of ($0.56) by ($1.53). The firm had revenue of $1.44 million for the quarter, compared to analyst estimates of $1.90 million. Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Arcadia Biosciences in a report on Tuesday, September 22nd. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, the company currently has an average rating of “Sell”.
Read Our Latest Analysis on Arcadia Biosciences
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications.
Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients.
See Also
- Five stocks we like better than Arcadia Biosciences
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
